tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Emma Nealon, 7 are a BUY (100%).
Analyst Emma Nealon, carries an average stock price target met ratio of 43.33% that have a potential upside of 90.45% achieved within 259 days.
Emma Nealon’s has documented 22 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on EQ, Equillium at 13-Aug-2023.
Analyst best performing recommendations are on EQ (EQUILLIUM).
The best stock recommendation documented was for EQ (EQUILLIUM) at 8/14/2023. The price target of $2.8 was fulfilled within 190 days with a profit of $2.01 (254.43%) receiving and performance score of 13.39.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$49
3 years 1 months 13 days ago
(01-Sep-2022)
0/3 (0%)
$39.17 (398.47%)
Hold
$20
$-0.01 (-0.05%)
$40
3 years 1 months 13 days ago
(01-Sep-2022)
1/2 (50%)
$0.02 (0.10%)
41
Hold
$20
$-0.01 (-0.05%)
$64
3 years 1 months 13 days ago
(01-Sep-2022)
1/2 (50%)
$0.02 (0.10%)
41
Hold
$20
$-0.01 (-0.05%)
$53
3 years 1 months 13 days ago
(01-Sep-2022)
1/4 (25%)
$0.02 (0.10%)
41
Buy
$23
$2.99 (14.94%)
$40
3 years 4 months 18 days ago
(26-May-2022)
0/4 (0%)
$17.23 (298.61%)
What Year was the first public recommendation made by Emma Nealon?
